Literature DB >> 34972717

Hypoxia-induced Maspin Expression Affects the Prognosis of Ovarian Clear Cell Carcinoma.

Eun Ji Lee1, Soo Jin Park1, Cheol Lee2, Ga Won Yim3, Jae Weon Kim1, Hee Seung Kim4.   

Abstract

BACKGROUND/AIM: To investigate the role of the expression of hypoxia-related genes on the prognosis of ovarian clear cell carcinoma (OCCC).
MATERIALS AND METHODS: Basal mRNA levels of eight hypoxia-related genes were compared. Cell viability was assayed after treating ES-2 cells under hypoxic conditions. The mRNA and protein levels were evaluated after the induction of hypoxia and administration of increased doses of N-acetylcysteine (NAC). Finally, the prognostic role of their expression levels was evaluated in 61 patients with OCCC.
RESULTS: The mRNA and protein levels of maspin increased gradually with the induction of hypoxia. Maspin protein expression decreased after treatment with paclitaxel and NAC. High expression of maspin was related to poor progression-free and overall survival in patients with OCCC (adjusted hazard ratios, 3.97 and 7.47; 95% confidence intervals=1.34-11.81, and 1.98-28.13).
CONCLUSION: High expression of maspin induced by hypoxia might be associated with poor prognosis of OCCC.
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Clear cell; hypoxia; maspin; ovarian cancer; prognosis

Mesh:

Substances:

Year:  2022        PMID: 34972717      PMCID: PMC8765144          DOI: 10.21873/invivo.12693

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  24 in total

1.  The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53.

Authors:  Bruce K Carney; Victoria Caruso Silva; Lynne Cassimeris
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-29

2.  Maspin is an angiogenesis inhibitor.

Authors:  M Zhang; O Volpert; Y H Shi; N Bouck
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

Review 3.  The regulation and role of extracellular glutathione peroxidase.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2005 Jan-Feb       Impact factor: 8.401

4.  Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clinicopathologic features.

Authors:  Moshira Mohamad Abd El-Wahed
Journal:  J Egypt Natl Canc Inst       Date:  2005-09

Review 5.  Molecular responses to hypoxia-inducible factor 1α and beyond.

Authors:  Jason Brocato; Yana Chervona; Max Costa
Journal:  Mol Pharmacol       Date:  2014-02-25       Impact factor: 4.436

6.  Clear-cell carcinoma of the ovary.

Authors:  K Fujiwara; D Shintani; T Nishikawa
Journal:  Ann Oncol       Date:  2016-04       Impact factor: 32.976

7.  Immunohistochemical evidence for the over-expression of Glutathione peroxidase 3 in clear cell type ovarian adenocarcinoma.

Authors:  Hee Joong Lee; Jin Hwan Do; Sumi Bae; Sanghwa Yang; Xianglon Zhang; Ahwon Lee; Young Jin Choi; Dong Choon Park; Woong Shick Ahn
Journal:  Med Oncol       Date:  2010-08-21       Impact factor: 3.064

8.  Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.

Authors:  L A Solomon; A R Munkarah; V L Schimp; M H Arabi; R T Morris; H Nassar; R Ali-Fehmi
Journal:  Gynecol Oncol       Date:  2006-01-27       Impact factor: 5.482

Review 9.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

10.  Relationship of hypoxia to metastatic ability in rodent tumours.

Authors:  K De Jaeger; M C Kavanagh; R P Hill
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

View more
  1 in total

1.  Computed Tomography Imaging-Based Radiogenomics Analysis Reveals Hypoxia Patterns and Immunological Characteristics in Ovarian Cancer.

Authors:  Songwei Feng; Tianyi Xia; Yu Ge; Ke Zhang; Xuan Ji; Shanhui Luo; Yang Shen
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.